Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Gnpda1em1/Cya
Common Name:
Gnpda1-KO
Product ID:
S-KO-19587
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Gnpda1-KO
Strain ID
KOCMP-26384-Gnpda1-B6J-VA
Gene Name
Gnpda1
Product ID
S-KO-19587
Gene Alias
GNPDA; Gnp1; Gnpi; oscillin
Background
C57BL/6JCya
NCBI ID
26384
Modification
Conventional knockout
Chromosome
18
Phenotype
MGI:1347054
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Gnpda1em1/Cya mice (Catalog S-KO-19587) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000063814
NCBI RefSeq
NM_011937
Target Region
Exon 4~5
Size of Effective Region
~3.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Gnpda1, glucosamine-6-phosphate deaminase 1, is an enzyme involved in the hexosamine biosynthetic pathway (HBP). It can convert glucosamine-6-phosphate (GlcN6P) back into fructose-6-phosphate (Fru6P) and ammonium, thus affecting protein N-glycosylation and O-linked-N-acetylglucosamine modification (O-GlcNAcylation), which are crucial for protein function and cellular responses to signals. The HBP and Gnpda1 are associated with metabolic diseases and cancer [3].

In hepatocellular carcinoma (HCC), Gnpda1 is highly expressed. High Gnpda1 expression is significantly associated with advanced tumor stage, TNM stage or grade, and is related to poor prognosis in HCC patients. Knockdown of Gnpda1 in SMMC-7721 and Huh7 cell lines inhibits the proliferation, migration, and invasion of HCC cells and promotes apoptosis, suggesting it may be a novel prognostic biomarker and therapeutic target for HCC [1].

In addition, Gnpda1 was identified as one of the up-regulated genes in the phlegm-dampness constitution, and gene functional analyses indicated that people with this constitution are susceptible to hyperlipemia and diabetes [2].

In colorectal cancer cells treated with caffeic acid phenethyl ester (CAPE), Gnpda1 was up-regulated, and these differentiated proteins may be potential molecular targets involved in the anti-cancer effect of CAPE [4].

An integrative analysis revealed Gnpda1 as a potential gene related to biopsychosocial factors among Taiwanese women with a family history of breast cancer. Gnpda1 hypomethylation was associated with poor overall survival in breast cancer, and it was also associated with the BRCA1, BRCA2, and pro-oncogenic actions of the androgen receptor in breast cancer [5].

A study on glycolysis-related gene pairs signature found that the IDUA_GNPDA1 pair was a significantly progressive factor for HCC patients, and a five-gene expression signature including Gnpda1 had a satisfactory prognostic value for overall survival of gastrointestinal cancer patients in the Asian population [6,7].

In gemcitabine-resistant pancreatic cancer cells, Gnpda1 was one of the mRNAs targeted by specific miRNAs, and gemcitabine resistance may alter the fraction of memory CD4+ T cells via the miRNA-Gnpda1 network [8].

In conclusion, Gnpda1 is an important enzyme in the hexosamine biosynthetic pathway. Its abnormal expression is closely related to the occurrence and development of various cancers such as HCC, breast cancer, colorectal cancer, and pancreatic cancer, as well as metabolic diseases like hyperlipemia and diabetes. Studies on Gnpda1 contribute to understanding the mechanisms of these diseases and may provide new directions for diagnosis, prognosis, and treatment.

References:
1. Li, Dezhi, Cheng, Xianyi, Zheng, Wei, Chen, Junhui. 2020. Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma. In Cancer management and research, 12, 4923-4935. doi:10.2147/CMAR.S250094. https://pubmed.ncbi.nlm.nih.gov/32606980/
2. Wang, Ji, Wang, Qi, Li, Lingru, Zhang, Yan, Han, Yuanyuan. . Phlegm-dampness constitution: genomics, susceptibility, adjustment and treatment with traditional Chinese medicine. In The American journal of Chinese medicine, 41, 253-62. doi:10.1142/S0192415X13500183. https://pubmed.ncbi.nlm.nih.gov/23548117/
3. Lara-Lemus, Roberto, Castillejos-López, Manuel, Aquino-Gálvez, Arnoldo. 2024. The Possible Roles of Glucosamine-6-Phosphate Deaminases in Ammonium Metabolism in Cancer. In International journal of molecular sciences, 25, . doi:10.3390/ijms252212054. https://pubmed.ncbi.nlm.nih.gov/39596123/
4. He, Yu-Jun, Li, Wan-Ling, Liu, Bao-Hua, Mou, Zhi-Rong, Wu, Yu-Zhang. . Identification of differential proteins in colorectal cancer cells treated with caffeic acid phenethyl ester. In World journal of gastroenterology, 20, 11840-9. doi:10.3748/wjg.v20.i33.11840. https://pubmed.ncbi.nlm.nih.gov/25206290/
5. Khairi, Sabiah, Wang, Chih-Yang, Anuraga, Gangga, Shen, Chen-Yang, Chung, Min-Huey. 2025. Integrative Analysis of DNA Methylation and microRNA Reveals GNPDA1 and SLC25A16 Related to Biopsychosocial Factors Among Taiwanese Women with a Family History of Breast Cancer. In Journal of personalized medicine, 15, . doi:10.3390/jpm15040134. https://pubmed.ncbi.nlm.nih.gov/40278313/
6. Zhou, Weige, Zhang, Shijing, Cai, Zheyou, Hou, Zheng-Kun, Chen, Xin-Lin. 2020. A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma. In PeerJ, 8, e9944. doi:10.7717/peerj.9944. https://pubmed.ncbi.nlm.nih.gov/33062428/
7. Xia, Rong, Tang, Hua, Shen, Jiemiao, Yang, Jinyou, Wang, Chao. 2021. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population. In Cancer cell international, 21, 154. doi:10.1186/s12935-021-01857-4. https://pubmed.ncbi.nlm.nih.gov/33663535/
8. Gu, Jianyou, Zhang, Junfeng, Huang, Wenjie, Fan, Yingfang, Wang, Huaizhi. . Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4+ T cells. In Annals of translational medicine, 8, 279. doi:10.21037/atm.2020.03.53. https://pubmed.ncbi.nlm.nih.gov/32355723/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest